PRECIPIO, INC. Noncash or Part Noncash Acquisition, Other Liabilities Assumed
PRECIPIO, INC. (PRPO) reported Noncash or Part Noncash Acquisition, Other Liabilities Assumed of $1.86 million for the 12-month period ending 2019-12-31, per its 10-K filed 2021-03-29.
Discontinued › Cash Flow › Operating Activities
us-gaap:NoncashOrPartNoncashAcquisitionOtherLiabilitiesAssumed1 · last filed 2021-03-29
- PRECIPIO, INC. noncash or part noncash acquisition, other liabilities assumed for the quarter ending 2018-12-31 was $740.00K.
- PRECIPIO, INC. noncash or part noncash acquisition, other liabilities assumed for the quarter ending 2018-09-30 was $720.00K.
- PRECIPIO, INC. noncash or part noncash acquisition, other liabilities assumed for fiscal 2019 was $1.86M, a 30.28% decline from fiscal 2018.
- PRECIPIO, INC. noncash or part noncash acquisition, other liabilities assumed for fiscal 2018 was $2.67M.
| Period end | Noncash or Part Noncash Acquisition, Other Liabilities Assumed 3 month | Noncash or Part Noncash Acquisition, Other Liabilities Assumed 6 month | Noncash or Part Noncash Acquisition, Other Liabilities Assumed 9 month | Noncash or Part Noncash Acquisition, Other Liabilities Assumed 12 month | Noncash or Part Noncash Acquisition, Other Liabilities Assumed 12 month as first filed |
|---|---|---|---|---|---|
| 2019-12-31 | $1.86M 10-K · filed 2021-03-29 | ||||
| 2018-12-31 | $740.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-27 | $1.46M derived: sum of 2 quarters · filed 2020-03-27 | $2.67M 10-K · filed 2020-03-27 | $2.67M 10-K · filed 2019-04-16 | |
| 2018-09-30 | $720.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-13 | $1.93M 10-Q · filed 2019-11-13 | |||
| 2018-06-30 | $1.21M 10-Q · filed 2019-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |